Position in VKTX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$3,655,510
-$114,624 QoQ
Shares Held
112,339
+4.8% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 95.01686858526425.ToString("F0")%
None 4.983131414735755.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $10,689,611,381 across 259 Biotechnology names. VKTX ranks #92 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,331,554 | $2,380,752,123 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,180,631 | $1,684,842,735 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,783,394 | $920,941,572 | |
| 4 | INSM |
INSMED Inc
|
4,523,921 | $739,751,561 | |
| 5 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 6 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in VKTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,655,510 | 112,339 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $3,770,134 | 107,167 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $2,872,322 | 109,297 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,542,779 | 95,954 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,052,289 | 84,981 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $35,123,321 | 872,846 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $55,473,613 | 876,222 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $37,524,663 | 707,879 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $57,066,588 | 695,934 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,560,046 | 137,563 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $9,570,999 | 864,589 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $13,387,740 | 825,894 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $2,428,226 | 258,322 | Shares | Defined | 2023-02-13 | |
| 2022-03-31 | $74,139 | 24,713 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $272,999 | 59,348 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $400,657 | 63,799 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $352,887 | 58,913 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $1,177,322 | 186,138 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $952,268 | 169,142 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $833,924 | 143,286 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,026,314 | 142,346 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $823,338 | 175,927 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||